> top > docs > PMC:1472690 > spans > 34794-35719 > annotations

PMC:1472690 / 34794-35719 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T18476 909-911 POS denotes 's
T18475 897-909 NN denotes manufacturer
T18474 893-896 DT denotes the
T18473 890-892 TO denotes to
T18472 880-889 VB denotes according
T18471 878-879 -RRB- denotes )
T18470 869-878 NNP denotes Pharmacia
T18469 868-869 -LRB- denotes (
T18468 860-867 NNP denotes Columns
T18467 854-859 NNP denotes Micro
T18466 849-853 NNP denotes G-50
T18465 843-848 NNP denotes Quant
T18464 837-842 NNP denotes Probe
T18463 831-836 VB denotes using
T18462 820-830 NN denotes filtration
T18461 816-819 NN denotes gel
T18460 812-815 IN denotes via
T18459 803-811 VB denotes purified
T18458 798-802 VB denotes were
T18457 791-797 NN denotes oligos
T18456 788-790 NN denotes ds
T18455 784-787 DT denotes the
T18454 782-783 -COMMA- denotes ,
T18453 772-782 RB denotes Afterwards
T18452 758-770 RB denotes respectively
T18451 756-757 -COMMA- denotes ,
T18450 748-756 NN denotes proteins
T18449 743-747 NN denotes NFκB
T18448 739-742 CC denotes and
T18447 734-738 NN denotes NFAT
T18446 731-733 IN denotes of
T18445 723-730 NN denotes binding
T18444 719-722 DT denotes the
T18443 715-718 IN denotes for
T18442 707-714 JJ denotes crucial
T18441 704-706 VB denotes be
T18440 701-703 TO denotes to
T18439 696-700 VB denotes seem
T18438 690-695 WDT denotes which
T18437 688-689 -COMMA- denotes ,
T18436 679-688 NN denotes sequences
T18435 674-678 IN denotes with
T18434 664-673 VB denotes interfere
T18433 661-663 TO denotes to
T18432 652-660 VB denotes reported
T18431 647-651 VB denotes been
T18430 642-646 VB denotes have
T18429 640-641 -RRB- denotes ]
T18428 638-640 CD denotes 55
T18427 637-638 -LRB- denotes [
T18426 628-636 NN denotes promoter
T18425 623-627 NN denotes TNFα
T18424 619-622 DT denotes the
T18423 616-618 IN denotes of
T18422 607-615 NN denotes sequence
T18421 597-606 NN denotes consensus
T18420 595-596 NN denotes κ
T18419 591-594 DT denotes the
T18418 588-590 IN denotes in
T18417 584-587 CC denotes and
T18416 582-583 -RRB- denotes ]
T18415 580-582 CD denotes 29
T18414 579-580 -LRB- denotes [
T18413 570-578 NN denotes promoter
T18412 565-569 NN denotes IFNγ
T18411 561-564 DT denotes the
T18410 558-560 IN denotes of
T18409 553-557 NN denotes site
T18408 550-552 NN denotes P2
T18407 546-549 DT denotes the
T18406 543-545 IN denotes in
T18405 533-542 NN denotes Mutations
T18404 524-531 NN denotes control
T18403 513-523 JJ denotes additional
T18402 510-512 DT denotes an
T18401 507-509 IN denotes as
T18400 502-506 VB denotes used
T18399 497-501 VB denotes were
T18398 490-496 NN denotes oligos
T18397 482-489 VB denotes mutated
T18396 480-481 -COMMA- denotes ,
T18395 474-480 NN denotes oligos
T18394 470-473 DT denotes the
T18393 467-469 IN denotes of
T18392 455-466 NN denotes specificity
T18391 447-454 NN denotes binding
T18390 443-446 DT denotes the
T18389 438-442 VB denotes test
T18388 435-437 TO denotes To
T18387 421-433 NN denotes instructions
T18386 418-420 POS denotes 's
T18385 406-418 NN denotes manufacturer
T18384 402-405 DT denotes the
T18383 399-401 TO denotes to
T18382 389-398 VB denotes according
T18381 387-388 -RRB- denotes )
T18380 380-387 NNP denotes Germany
T18379 378-379 -COMMA- denotes ,
T18378 370-378 NNP denotes Freiburg
T18377 368-369 -COMMA- denotes ,
T18376 365-368 NNP denotes LKB
T18375 355-364 NNP denotes Pharmacia
T18374 353-354 -COMMA- denotes ,
T18373 350-353 NN denotes Kit
T18372 346-349 NN denotes PNK
T18371 345-346 -LRB- denotes (
T18370 341-344 NN denotes Kit
T18369 307-340 NN denotes Ready-To-Go-Polynucleotide-Kinase
T18368 303-306 DT denotes the
T18367 297-302 VB denotes using
T18366 295-296 -RRB- denotes )
T18365 288-295 NNP denotes Germany
T18364 286-287 -COMMA- denotes ,
T18363 274-286 NNP denotes Braunschweig
T18362 272-273 -COMMA- denotes ,
T18361 264-272 NNP denotes Amersham
T18360 262-263 -COMMA- denotes ,
T18359 255-262 NN denotes Ci/mmol
T18358 249-254 CD denotes 3,000
T18357 248-249 -LRB- denotes (
T18356 238-247 NN denotes 5'γ-P-ATP
T18355 233-237 IN denotes with
T18354 221-232 JJ denotes 32P-labeled
T18353 217-220 CC denotes and
T18352 215-216 -RRB- denotes )
T18351 208-215 NNP denotes Germany
T18350 206-207 -COMMA- denotes ,
T18349 200-206 NNP denotes Berlin
T18348 198-199 -COMMA- denotes ,
T18347 191-198 NNP denotes Molbiol
T18346 187-190 NNP denotes TIB
T18345 186-187 -LRB- denotes (
T18344 184-185 -COMMA- denotes ,
T18343 183-184 -RRB- denotes )
T18342 182-183 CD denotes 1
T18341 176-181 JJ denotes Table
T18340 173-175 IN denotes in
T18339 161-172 VB denotes illustrated
T18338 160-161 -LRB- denotes (
T18337 153-159 NN denotes oligos
T18336 151-152 -RRB- denotes )
T18335 149-151 NN denotes ss
T18334 148-149 -LRB- denotes (
T18333 139-147 JJ denotes stranded
T18332 132-138 JJ denotes single
T18331 127-131 IN denotes from
T18330 115-126 VB denotes synthesised
T18329 110-114 VB denotes were
T18328 100-109 NN denotes promoters
T18327 95-99 NN denotes IL-6
T18326 91-94 CC denotes and
T18325 86-90 NN denotes IFNγ
T18324 84-85 -COMMA- denotes ,
T18323 80-84 NN denotes IL-8
T18322 78-79 -COMMA- denotes ,
T18321 74-78 NN denotes TNFα
T18320 70-73 DT denotes the
T18319 65-69 IN denotes from
T18318 63-64 -RRB- denotes )
T18317 57-63 NN denotes oligos
T18316 56-57 -LRB- denotes (
T18315 39-55 NN denotes oligonucleotides
T18314 37-38 -RRB- denotes )
T18313 35-37 NN denotes ds
T18312 34-35 -LRB- denotes (
T18311 18-33 JJ denotes double-stranded
T18310 4-17 JJ denotes complementary
T18309 0-3 DT denotes The
T18477 912-924 NN denotes instructions
R12475 T18313 T18312 arg2Of ds,(
R12476 T18314 T18312 arg3Of ),(
R12477 T18315 T18309 arg1Of oligonucleotides,The
R12478 T18315 T18310 arg1Of oligonucleotides,complementary
R12479 T18315 T18311 arg1Of oligonucleotides,double-stranded
R12480 T18315 T18312 arg1Of oligonucleotides,(
R12481 T18315 T18316 arg1Of oligonucleotides,(
R12482 T18315 T18319 arg1Of oligonucleotides,from
R12483 T18315 T18329 arg1Of oligonucleotides,were
R12484 T18315 T18330 arg2Of oligonucleotides,synthesised
R12485 T18315 T18354 arg1Of oligonucleotides,32P-labeled
R12486 T18317 T18316 arg2Of oligos,(
R12487 T18318 T18316 arg3Of ),(
R12488 T18321 T18322 arg1Of TNFα,","
R12489 T18322 T18324 arg1Of ",",","
R12490 T18323 T18322 arg2Of IL-8,","
R12491 T18324 T18326 arg1Of ",",and
R12492 T18325 T18324 arg2Of IFNγ,","
R12493 T18327 T18326 arg2Of IL-6,and
R12494 T18328 T18319 arg2Of promoters,from
R12495 T18328 T18320 arg1Of promoters,the
R12496 T18328 T18321 arg1Of promoters,TNFα
R12497 T18328 T18323 arg1Of promoters,IL-8
R12498 T18328 T18325 arg1Of promoters,IFNγ
R12499 T18328 T18327 arg1Of promoters,IL-6
R12500 T18330 T18331 arg1Of synthesised,from
R12501 T18330 T18353 arg1Of synthesised,and
R12502 T18333 T18332 arg1Of stranded,single
R12503 T18333 T18334 arg1Of stranded,(
R12504 T18335 T18334 arg2Of ss,(
R12505 T18336 T18334 arg3Of ),(
R12506 T18337 T18331 arg2Of oligos,from
R12507 T18337 T18333 arg1Of oligos,stranded
R12508 T18337 T18338 arg1Of oligos,(
R12509 T18337 T18344 arg1Of oligos,","
R12510 T18337 T18345 arg1Of oligos,(
R12511 T18339 T18338 arg2Of illustrated,(
R12512 T18339 T18340 arg1Of illustrated,in
R12513 T18342 T18340 arg2Of 1,in
R12514 T18342 T18341 arg1Of 1,Table
R12515 T18343 T18338 arg3Of ),(
R12516 T18347 T18345 arg2Of Molbiol,(
R12517 T18347 T18346 arg1Of Molbiol,TIB
R12518 T18347 T18348 arg1Of Molbiol,","
R12519 T18349 T18348 arg2Of Berlin,","
R12520 T18349 T18350 arg1Of Berlin,","
R12521 T18351 T18350 arg2Of Germany,","
R12522 T18352 T18345 arg3Of ),(
R12523 T18353 T18329 arg2Of and,were
R12524 T18354 T18353 arg2Of 32P-labeled,and
R12525 T18354 T18355 arg1Of 32P-labeled,with
R12526 T18356 T18355 arg2Of 5'γ-P-ATP,with
R12527 T18356 T18357 arg1Of 5'γ-P-ATP,(
R12528 T18356 T18367 arg1Of 5'γ-P-ATP,using
R12529 T18359 T18357 arg2Of Ci/mmol,(
R12530 T18359 T18358 arg1Of Ci/mmol,"3,000"
R12531 T18359 T18360 arg1Of Ci/mmol,","
R12532 T18359 T18364 arg1Of Ci/mmol,","
R12533 T18361 T18362 arg1Of Amersham,","
R12534 T18362 T18360 arg2Of ",",","
R12535 T18363 T18362 arg2Of Braunschweig,","
R12536 T18365 T18364 arg2Of Germany,","
R12537 T18366 T18357 arg3Of ),(
R12538 T18367 T18382 arg1Of using,according
R12539 T18370 T18367 arg2Of Kit,using
R12540 T18370 T18368 arg1Of Kit,the
R12541 T18370 T18369 arg1Of Kit,Ready-To-Go-Polynucleotide-Kinase
R12542 T18370 T18371 arg1Of Kit,(
R12543 T18373 T18372 arg1Of Kit,PNK
R12544 T18373 T18374 arg1Of Kit,","
R12545 T18373 T18377 arg1Of Kit,","
R12546 T18376 T18374 arg2Of LKB,","
R12547 T18376 T18375 arg1Of LKB,Pharmacia
R12548 T18377 T18371 arg2Of ",",(
R12549 T18378 T18377 arg2Of Freiburg,","
R12550 T18378 T18379 arg1Of Freiburg,","
R12551 T18380 T18379 arg2Of Germany,","
R12552 T18381 T18371 arg3Of ),(
R12553 T18383 T18382 arg2Of to,according
R12554 T18385 T18384 arg1Of manufacturer,the
R12555 T18385 T18386 arg2Of manufacturer,'s
R12556 T18387 T18383 arg2Of instructions,to
R12557 T18387 T18386 arg1Of instructions,'s
R12558 T18389 T18388 arg1Of test,To
R12559 T18392 T18389 arg2Of specificity,test
R12560 T18392 T18390 arg1Of specificity,the
R12561 T18392 T18391 arg1Of specificity,binding
R12562 T18392 T18393 arg1Of specificity,of
R12563 T18395 T18393 arg2Of oligos,of
R12564 T18395 T18394 arg1Of oligos,the
R12565 T18398 T18397 arg2Of oligos,mutated
R12566 T18398 T18399 arg1Of oligos,were
R12567 T18398 T18400 arg2Of oligos,used
R12568 T18400 T18388 modOf used,To
R12569 T18400 T18396 arg1Of used,","
R12570 T18400 T18399 arg2Of used,were
R12571 T18400 T18401 arg1Of used,as
R12572 T18404 T18401 arg2Of control,as
R12573 T18404 T18402 arg1Of control,an
R12574 T18404 T18403 arg1Of control,additional
R12575 T18405 T18406 arg1Of Mutations,in
R12576 T18405 T18418 arg1Of Mutations,in
R12577 T18405 T18427 arg1Of Mutations,[
R12578 T18405 T18430 arg1Of Mutations,have
R12579 T18405 T18431 arg1Of Mutations,been
R12580 T18405 T18432 arg2Of Mutations,reported
R12581 T18405 T18434 arg1Of Mutations,interfere
R12582 T18406 T18417 arg1Of in,and
R12583 T18409 T18406 arg2Of site,in
R12584 T18409 T18407 arg1Of site,the
R12585 T18409 T18408 arg1Of site,P2
R12586 T18409 T18410 arg1Of site,of
R12587 T18413 T18410 arg2Of promoter,of
R12588 T18413 T18411 arg1Of promoter,the
R12589 T18413 T18412 arg1Of promoter,IFNγ
R12590 T18413 T18414 arg1Of promoter,[
R12591 T18415 T18414 arg2Of 29,[
R12592 T18416 T18414 arg3Of ],[
R12593 T18418 T18417 arg2Of in,and
R12594 T18422 T18418 arg2Of sequence,in
R12595 T18422 T18419 arg1Of sequence,the
R12596 T18422 T18420 arg1Of sequence,κ
R12597 T18422 T18421 arg1Of sequence,consensus
R12598 T18422 T18423 arg1Of sequence,of
R12599 T18426 T18423 arg2Of promoter,of
R12600 T18426 T18424 arg1Of promoter,the
R12601 T18426 T18425 arg1Of promoter,TNFα
R12602 T18428 T18427 arg2Of 55,[
R12603 T18429 T18427 arg3Of ],[
R12604 T18432 T18430 arg2Of reported,have
R12605 T18432 T18431 arg2Of reported,been
R12606 T18434 T18432 arg3Of interfere,reported
R12607 T18434 T18433 arg1Of interfere,to
R12608 T18434 T18435 arg1Of interfere,with
R12609 T18436 T18435 arg2Of sequences,with
R12610 T18436 T18437 arg1Of sequences,","
R12611 T18436 T18438 arg1Of sequences,which
R12612 T18436 T18439 arg1Of sequences,seem
R12613 T18436 T18441 arg1Of sequences,be
R12614 T18436 T18442 arg1Of sequences,crucial
R12615 T18441 T18439 arg2Of be,seem
R12616 T18441 T18440 arg1Of be,to
R12617 T18441 T18451 arg1Of be,","
R12618 T18441 T18452 arg1Of be,respectively
R12619 T18442 T18441 arg2Of crucial,be
R12620 T18442 T18443 arg1Of crucial,for
R12621 T18445 T18443 arg2Of binding,for
R12622 T18445 T18444 arg1Of binding,the
R12623 T18445 T18446 arg1Of binding,of
R12624 T18447 T18448 arg1Of NFAT,and
R12625 T18449 T18448 arg2Of NFκB,and
R12626 T18450 T18446 arg2Of proteins,of
R12627 T18450 T18447 arg1Of proteins,NFAT
R12628 T18450 T18449 arg1Of proteins,NFκB
R12629 T18457 T18455 arg1Of oligos,the
R12630 T18457 T18456 arg1Of oligos,ds
R12631 T18457 T18458 arg1Of oligos,were
R12632 T18457 T18459 arg2Of oligos,purified
R12633 T18457 T18463 arg1Of oligos,using
R12634 T18459 T18453 arg1Of purified,Afterwards
R12635 T18459 T18454 arg1Of purified,","
R12636 T18459 T18458 arg2Of purified,were
R12637 T18459 T18460 arg1Of purified,via
R12638 T18459 T18463 modOf purified,using
R12639 T18462 T18460 arg2Of filtration,via
R12640 T18462 T18461 arg1Of filtration,gel
R12641 T18468 T18464 arg1Of Columns,Probe
R12642 T18468 T18465 arg1Of Columns,Quant
R12643 T18468 T18466 arg1Of Columns,G-50
R12644 T18468 T18467 arg1Of Columns,Micro
R12645 T18468 T18469 arg1Of Columns,(
R12646 T18468 T18472 arg1Of Columns,according
R12647 T18470 T18469 arg2Of Pharmacia,(
R12648 T18471 T18469 arg3Of ),(
R12649 T18473 T18472 arg2Of to,according
R12650 T18475 T18474 arg1Of manufacturer,the
R12651 T18475 T18476 arg2Of manufacturer,'s
R12652 T18476 T18473 arg2Of 's,to
R12653 T18477 T18463 arg2Of instructions,using
R12654 T18477 T18468 arg1Of instructions,Columns

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T18289 734-738 Protein denotes NFAT
T18288 623-627 Protein denotes TNFα
T18287 565-569 Protein denotes IFNγ
T18286 95-99 Protein denotes IL-6
T18285 86-90 Protein denotes IFNγ
T18284 80-84 Protein denotes IL-8
T18283 74-78 Protein denotes TNFα

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T18480 80-84 http://www.uniprot.org/uniprot/P10145 denotes IL-8
T18479 623-627 http://www.uniprot.org/uniprot/P01375 denotes TNFα
T18478 74-78 http://www.uniprot.org/uniprot/P01375 denotes TNFα
T18481 95-99 http://www.uniprot.org/uniprot/P05231 denotes IL-6

GO-BP

Id Subject Object Predicate Lexical cue
T18272 346-349 http://purl.obolibrary.org/obo/GO_0051731 denotes PNK

GO-MF

Id Subject Object Predicate Lexical cue
T18295 723-738 http://purl.obolibrary.org/obo/GO_0051525 denotes binding of NFAT
T18294 723-730 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T18293 447-454 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T18292 346-349 http://purl.obolibrary.org/obo/GO_0051731 denotes PNK
T18291 95-99 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T18290 80-84 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8

sentences

Id Subject Object Predicate Lexical cue
T18271 772-925 Sentence denotes Afterwards, the ds oligos were purified via gel filtration using Probe Quant G-50 Micro Columns (Pharmacia) according to the manufacturer's instructions.
T18270 533-771 Sentence denotes Mutations in the P2 site of the IFNγ promoter [29] and in the κ consensus sequence of the TNFα promoter [55] have been reported to interfere with sequences, which seem to be crucial for the binding of NFAT and NFκB proteins, respectively.
T18269 435-532 Sentence denotes To test the binding specificity of the oligos, mutated oligos were used as an additional control.
T18268 0-434 Sentence denotes The complementary double-stranded (ds) oligonucleotides (oligos) from the TNFα, IL-8, IFNγ and IL-6 promoters were synthesised from single stranded (ss) oligos (illustrated in Table 1), (TIB Molbiol, Berlin, Germany) and 32P-labeled with 5'γ-P-ATP (3,000 Ci/mmol, Amersham, Braunschweig, Germany) using the Ready-To-Go-Polynucleotide-Kinase Kit (PNK Kit, Pharmacia LKB, Freiburg, Germany) according to the manufacturer's instructions.
T240 0-434 Sentence denotes The complementary double-stranded (ds) oligonucleotides (oligos) from the TNFα, IL-8, IFNγ and IL-6 promoters were synthesised from single stranded (ss) oligos (illustrated in Table 1), (TIB Molbiol, Berlin, Germany) and 32P-labeled with 5'γ-P-ATP (3,000 Ci/mmol, Amersham, Braunschweig, Germany) using the Ready-To-Go-Polynucleotide-Kinase Kit (PNK Kit, Pharmacia LKB, Freiburg, Germany) according to the manufacturer's instructions.
T241 435-532 Sentence denotes To test the binding specificity of the oligos, mutated oligos were used as an additional control.
T242 533-771 Sentence denotes Mutations in the P2 site of the IFNγ promoter [29] and in the κ consensus sequence of the TNFα promoter [55] have been reported to interfere with sequences, which seem to be crucial for the binding of NFAT and NFκB proteins, respectively.
T243 772-925 Sentence denotes Afterwards, the ds oligos were purified via gel filtration using Probe Quant G-50 Micro Columns (Pharmacia) according to the manufacturer's instructions.

simple1

Id Subject Object Predicate Lexical cue
T18302 734-738 Protein denotes NFAT
T18301 623-627 Protein denotes TNFα
T18300 565-569 Protein denotes IFNγ
T18299 95-99 Protein denotes IL-6
T18298 86-90 Protein denotes IFNγ
T18297 80-84 Protein denotes IL-8
T18296 74-78 Protein denotes TNFα

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T18764 707-714 Positive_regulation denotes crucial
T18763 723-730 Binding denotes binding
T18762 734-738 Protein denotes NFAT
T18761 623-627 Protein denotes TNFα
T18760 565-569 Protein denotes IFNγ
T18759 95-99 Protein denotes IL-6
T18758 86-90 Protein denotes IFNγ
T18757 80-84 Protein denotes IL-8
T18756 74-78 Protein denotes TNFα
R12861 T18762 T18763 themeOf NFAT,binding
R12862 T18763 T18764 themeOf binding,crucial

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T18490 723-730 Binding denotes binding
T18489 707-714 Positive_regulation denotes crucial
T18488 734-738 Protein denotes NFAT
T18487 623-627 Protein denotes TNFα
T18486 565-569 Protein denotes IFNγ
T18485 95-99 Protein denotes IL-6
T18484 86-90 Protein denotes IFNγ
T18483 80-84 Protein denotes IL-8
T18482 74-78 Protein denotes TNFα
R12655 T18488 T18490 themeOf NFAT,binding
R12656 T18490 T18489 themeOf binding,crucial

DLUT931

Id Subject Object Predicate Lexical cue
T18521 707-714 Positive_regulation denotes crucial
T18520 723-730 Binding denotes binding
T18519 734-738 Protein denotes NFAT
T18518 623-627 Protein denotes TNFα
T18517 565-569 Protein denotes IFNγ
T18516 95-99 Protein denotes IL-6
T18515 86-90 Protein denotes IFNγ
T18514 80-84 Protein denotes IL-8
T18513 74-78 Protein denotes TNFα
R12663 T18519 T18520 themeOf NFAT,binding
R12664 T18520 T18521 themeOf binding,crucial

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T18755 690-770 Regulation denotes which seem to be crucial for the binding of NFAT and NFκB proteins, respectively
T18754 715-756 Binding denotes for the binding of NFAT and NFκB proteins
T18753 74-78 Protein denotes TNFα
T18752 743-747 Protein denotes NFκB
T18751 837-848 Entity denotes Probe Quant
T18750 616-641 Entity denotes of the TNFα promoter [55]
T18749 561-583 Entity denotes the IFNγ promoter [29]
T18748 95-99 Protein denotes IL-6
T18747 319-333 Entity denotes Polynucleotide
T18745 623-627 Protein denotes TNFα
T18744 86-90 Protein denotes IFNγ
T18743 731-756 Protein denotes of NFAT and NFκB proteins
T18742 346-349 Protein denotes PNK
T18741 784-797 Entity denotes the ds oligos
T18740 565-569 Protein denotes IFNγ
T18739 334-340 Protein denotes Kinase
T18738 546-596 Entity denotes the P2 site of the IFNγ promoter [29] and in the κ
T18737 70-109 Entity denotes the TNFα, IL-8, IFNγ and IL-6 promoters
T18736 80-84 Protein denotes IL-8
T18735 346-353 Protein denotes PNK Kit
T18734 816-819 Entity denotes gel
T18733 35-37 Entity denotes ds
T18732 39-64 Entity denotes oligonucleotides (oligos)
T18731 734-738 Protein denotes NFAT
T18730 303-344 Protein denotes the Ready-To-Go-Polynucleotide-Kinase Kit
R12857 T18743 T18754 themeOf of NFAT and NFκB proteins,for the binding of NFAT and NFκB proteins
R12858 T18749 T18740 partOf the IFNγ promoter [29],IFNγ
R12859 T18750 T18745 partOf of the TNFα promoter [55],TNFα
R12860 T18754 T18755 themeOf for the binding of NFAT and NFκB proteins,"which seem to be crucial for the binding of NFAT and NFκB proteins, respectively"

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T18714 924-925 . denotes .
T18713 912-924 NNS denotes instructions
T18712 909-911 POS denotes 's
T18711 897-909 NN denotes manufacturer
T18710 893-896 DT denotes the
T18709 890-892 TO denotes to
T18708 880-889 VBG denotes according
T18707 878-879 -RRB- denotes )
T18706 869-878 NNP denotes Pharmacia
T18705 868-869 -LRB- denotes (
T18704 860-867 NNP denotes Columns
T18703 854-859 NNP denotes Micro
T18702 849-853 NNP denotes G-50
T18701 843-848 NN denotes Quant
T18700 837-842 NNP denotes Probe
T18699 831-836 VBG denotes using
T18698 820-830 NN denotes filtration
T18697 816-819 NN denotes gel
T18696 812-815 IN denotes via
T18695 803-811 VBN denotes purified
T18694 798-802 VBD denotes were
T18693 791-797 NNS denotes oligos
T18692 788-790 NNS denotes ds
T18691 784-787 DT denotes the
T18690 782-783 , denotes ,
T18689 772-782 RB denotes Afterwards
T18688 770-771 . denotes .
T18687 758-770 RB denotes respectively
T18686 756-757 , denotes ,
T18685 748-756 NNS denotes proteins
T18684 743-747 NNP denotes NFκB
T18683 739-742 CC denotes and
T18682 734-738 NNP denotes NFAT
T18681 731-733 IN denotes of
T18680 723-730 JJ denotes binding
T18679 719-722 DT denotes the
T18678 715-718 IN denotes for
T18677 707-714 JJ denotes crucial
T18676 704-706 VB denotes be
T18675 701-703 TO denotes to
T18674 696-700 VBP denotes seem
T18673 690-695 WDT denotes which
T18672 688-689 , denotes ,
T18671 679-688 NNS denotes sequences
T18670 674-678 IN denotes with
T18669 664-673 VB denotes interfere
T18668 661-663 TO denotes to
T18667 652-660 VBN denotes reported
T18666 647-651 VBN denotes been
T18665 642-646 VBP denotes have
T18664 640-641 NNP denotes ]
T18663 638-640 CD denotes 55
T18662 637-638 NNP denotes [
T18661 628-636 NN denotes promoter
T18660 623-627 NNP denotes TNFα
T18659 619-622 DT denotes the
T18658 616-618 IN denotes of
T18657 607-615 NN denotes sequence
T18656 597-606 NN denotes consensus
T18655 595-596 NN denotes κ
T18654 591-594 DT denotes the
T18653 588-590 IN denotes in
T18652 584-587 CC denotes and
T18651 582-583 NNP denotes ]
T18650 580-582 CD denotes 29
T18649 579-580 NNP denotes [
T18648 570-578 NN denotes promoter
T18647 565-569 NNP denotes IFNγ
T18646 561-564 DT denotes the
T18645 558-560 IN denotes of
T18644 553-557 NN denotes site
T18643 550-552 NNP denotes P2
T18642 546-549 DT denotes the
T18641 543-545 IN denotes in
T18640 533-542 NNS denotes Mutations
T18639 531-532 . denotes .
T18638 524-531 NN denotes control
T18637 513-523 JJ denotes additional
T18636 510-512 DT denotes an
T18635 507-509 IN denotes as
T18634 502-506 VBN denotes used
T18633 497-501 VBD denotes were
T18632 490-496 NNS denotes oligos
T18631 482-489 VBN denotes mutated
T18630 480-481 , denotes ,
T18629 474-480 NNS denotes oligos
T18628 470-473 DT denotes the
T18627 467-469 IN denotes of
T18626 455-466 NN denotes specificity
T18625 447-454 JJ denotes binding
T18624 443-446 DT denotes the
T18623 438-442 VB denotes test
T18622 435-437 TO denotes To
T18621 433-434 . denotes .
T18620 421-433 NNS denotes instructions
T18619 418-420 POS denotes 's
T18618 406-418 NN denotes manufacturer
T18617 402-405 DT denotes the
T18616 399-401 TO denotes to
T18615 389-398 VBG denotes according
T18614 387-388 -RRB- denotes )
T18613 380-387 NNP denotes Germany
T18612 378-379 , denotes ,
T18611 370-378 NNP denotes Freiburg
T18610 368-369 , denotes ,
T18609 365-368 NNP denotes LKB
T18608 355-364 NNP denotes Pharmacia
T18607 353-354 , denotes ,
T18606 350-353 NNP denotes Kit
T18605 346-349 NNP denotes PNK
T18604 345-346 -LRB- denotes (
T18603 341-344 NNP denotes Kit
T18602 307-340 NNP denotes Ready-To-Go-Polynucleotide-Kinase
T18601 303-306 DT denotes the
T18600 297-302 VBG denotes using
T18599 295-296 -RRB- denotes )
T18595 272-273 , denotes ,
T18594 264-272 NNP denotes Amersham
T18593 262-263 , denotes ,
T18592 255-262 NNP denotes Ci/mmol
T18591 249-254 CD denotes 3,000
T18590 248-249 -LRB- denotes (
T18589 240-247 NNP denotes γ-P-ATP
T18588 239-240 '' denotes '
T18587 238-239 CD denotes 5
T18586 233-237 IN denotes with
T18585 221-232 JJ denotes 32P-labeled
T18584 217-220 CC denotes and
T18583 215-216 -RRB- denotes )
T18582 208-215 NNP denotes Germany
T18581 206-207 , denotes ,
T18580 200-206 NNP denotes Berlin
T18579 198-199 , denotes ,
T18578 191-198 NNP denotes Molbiol
T18577 187-190 NNP denotes TIB
T18576 186-187 -LRB- denotes (
T18575 184-185 , denotes ,
T18574 183-184 -RRB- denotes )
T18573 182-183 CD denotes 1
T18572 176-181 NNP denotes Table
T18571 173-175 IN denotes in
T18570 161-172 VBN denotes illustrated
T18569 160-161 -LRB- denotes (
T18568 153-159 NNS denotes oligos
T18567 151-152 -RRB- denotes )
T18566 149-151 NN denotes ss
T18565 148-149 -LRB- denotes (
T18564 139-147 VBN denotes stranded
T18563 132-138 JJ denotes single
T18562 127-131 IN denotes from
T18561 115-126 VBN denotes synthesised
T18560 110-114 VBD denotes were
T18559 100-109 NNS denotes promoters
T18558 95-99 NNP denotes IL-6
T18557 91-94 CC denotes and
T18556 86-90 NNP denotes IFNγ
T18555 84-85 , denotes ,
T18554 80-84 NNP denotes IL-8
T18553 78-79 , denotes ,
T18552 74-78 NNP denotes TNFα
T18551 70-73 DT denotes the
T18550 65-69 IN denotes from
T18549 63-64 -RRB- denotes )
T18548 57-63 NNS denotes oligos
T18547 56-57 -LRB- denotes (
T18546 39-55 NNS denotes oligonucleotides
T18545 37-38 -RRB- denotes )
T18544 35-37 NNS denotes ds
T18543 34-35 -LRB- denotes (
T18542 18-33 JJ denotes double-stranded
T18541 4-17 JJ denotes complementary
T18540 0-3 DT denotes The
T18598 288-295 NNP denotes Germany
T18597 286-287 , denotes ,
T18596 274-286 NNP denotes Braunschweig
R12676 T18540 T18542 det The,double-stranded
R12677 T18541 T18542 amod complementary,double-stranded
R12678 T18542 T18615 nsubj double-stranded,according
R12679 T18543 T18544 punct (,ds
R12680 T18544 T18561 nsubjpass ds,synthesised
R12681 T18545 T18544 punct ),ds
R12682 T18546 T18544 appos oligonucleotides,ds
R12683 T18547 T18548 punct (,oligos
R12684 T18548 T18546 appos oligos,oligonucleotides
R12685 T18549 T18546 punct ),oligonucleotides
R12686 T18550 T18544 prep from,ds
R12687 T18551 T18552 det the,TNFα
R12688 T18552 T18550 pobj TNFα,from
R12689 T18553 T18552 punct ",",TNFα
R12690 T18554 T18552 conj IL-8,TNFα
R12691 T18555 T18554 punct ",",IL-8
R12692 T18556 T18554 conj IFNγ,IL-8
R12693 T18557 T18556 cc and,IFNγ
R12694 T18558 T18556 conj IL-6,IFNγ
R12695 T18559 T18550 pobj promoters,from
R12696 T18560 T18561 auxpass were,synthesised
R12697 T18561 T18542 relcl synthesised,double-stranded
R12698 T18562 T18561 prep from,synthesised
R12699 T18563 T18564 amod single,stranded
R12700 T18564 T18561 conj stranded,synthesised
R12701 T18565 T18566 punct (,ss
R12702 T18566 T18564 appos ss,stranded
R12703 T18567 T18566 punct ),ss
R12704 T18568 T18566 appos oligos,ss
R12705 T18569 T18570 punct (,illustrated
R12706 T18570 T18568 acl illustrated,oligos
R12707 T18571 T18570 prep in,illustrated
R12708 T18572 T18571 pobj Table,in
R12709 T18573 T18572 nummod 1,Table
R12710 T18574 T18566 punct ),ss
R12711 T18575 T18564 punct ",",stranded
R12712 T18576 T18561 punct (,synthesised
R12713 T18577 T18578 compound TIB,Molbiol
R12714 T18578 T18600 nsubj Molbiol,using
R12715 T18579 T18578 punct ",",Molbiol
R12716 T18580 T18578 conj Berlin,Molbiol
R12717 T18581 T18580 punct ",",Berlin
R12718 T18582 T18580 conj Germany,Berlin
R12719 T18583 T18582 punct ),Germany
R12720 T18584 T18578 cc and,Molbiol
R12721 T18585 T18578 conj 32P-labeled,Molbiol
R12722 T18586 T18585 prep with,32P-labeled
R12723 T18587 T18589 nummod 5,γ-P-ATP
R12724 T18588 T18589 punct ',γ-P-ATP
R12725 T18589 T18586 pobj γ-P-ATP,with
R12726 T18590 T18592 punct (,Ci/mmol
R12727 T18591 T18592 nummod "3,000",Ci/mmol
R12728 T18592 T18589 appos Ci/mmol,γ-P-ATP
R12729 T18593 T18592 punct ",",Ci/mmol
R12730 T18594 T18592 conj Amersham,Ci/mmol
R12731 T18595 T18594 punct ",",Amersham
R12732 T18596 T18594 conj Braunschweig,Amersham
R12733 T18597 T18596 punct ",",Braunschweig
R12734 T18598 T18596 conj Germany,Braunschweig
R12735 T18599 T18589 punct ),γ-P-ATP
R12736 T18600 T18561 advcl using,synthesised
R12737 T18601 T18603 det the,Kit
R12738 T18602 T18603 compound Ready-To-Go-Polynucleotide-Kinase,Kit
R12739 T18603 T18600 dobj Kit,using
R12740 T18604 T18606 punct (,Kit
R12741 T18605 T18606 compound PNK,Kit
R12742 T18606 T18603 appos Kit,Kit
R12743 T18607 T18606 punct ",",Kit
R12744 T18608 T18609 compound Pharmacia,LKB
R12745 T18609 T18606 conj LKB,Kit
R12746 T18610 T18609 punct ",",LKB
R12747 T18611 T18609 conj Freiburg,LKB
R12748 T18612 T18611 punct ",",Freiburg
R12749 T18613 T18611 conj Germany,Freiburg
R12750 T18614 T18603 punct ),Kit
R12751 T18615 T18615 ROOT according,according
R12752 T18616 T18615 prep to,according
R12753 T18617 T18618 det the,manufacturer
R12754 T18618 T18620 poss manufacturer,instructions
R12755 T18619 T18618 case 's,manufacturer
R12756 T18620 T18616 pobj instructions,to
R12757 T18621 T18615 punct .,according
R12758 T18622 T18623 aux To,test
R12759 T18623 T18634 advcl test,used
R12760 T18624 T18626 det the,specificity
R12761 T18625 T18626 amod binding,specificity
R12762 T18626 T18623 dobj specificity,test
R12763 T18627 T18626 prep of,specificity
R12764 T18628 T18629 det the,oligos
R12765 T18629 T18627 pobj oligos,of
R12766 T18630 T18634 punct ",",used
R12767 T18631 T18632 amod mutated,oligos
R12768 T18632 T18634 nsubjpass oligos,used
R12769 T18633 T18634 auxpass were,used
R12770 T18634 T18634 ROOT used,used
R12771 T18635 T18634 prep as,used
R12772 T18636 T18638 det an,control
R12773 T18637 T18638 amod additional,control
R12774 T18638 T18635 pobj control,as
R12775 T18639 T18634 punct .,used
R12776 T18640 T18667 nsubjpass Mutations,reported
R12777 T18641 T18640 prep in,Mutations
R12778 T18642 T18644 det the,site
R12779 T18643 T18644 compound P2,site
R12780 T18644 T18641 pobj site,in
R12781 T18645 T18644 prep of,site
R12782 T18646 T18648 det the,promoter
R12783 T18647 T18648 compound IFNγ,promoter
R12784 T18648 T18645 pobj promoter,of
R12785 T18649 T18651 nmod [,]
R12786 T18650 T18651 nummod 29,]
R12787 T18651 T18648 appos ],promoter
R12788 T18652 T18641 cc and,in
R12789 T18653 T18641 conj in,in
R12790 T18654 T18657 det the,sequence
R12791 T18655 T18657 compound κ,sequence
R12792 T18656 T18657 compound consensus,sequence
R12793 T18657 T18653 pobj sequence,in
R12794 T18658 T18657 prep of,sequence
R12795 T18659 T18661 det the,promoter
R12796 T18660 T18661 compound TNFα,promoter
R12797 T18661 T18658 pobj promoter,of
R12798 T18662 T18664 nmod [,]
R12799 T18663 T18664 nummod 55,]
R12800 T18664 T18661 appos ],promoter
R12801 T18665 T18667 aux have,reported
R12802 T18666 T18667 auxpass been,reported
R12803 T18667 T18667 ROOT reported,reported
R12804 T18668 T18669 aux to,interfere
R12805 T18669 T18667 xcomp interfere,reported
R12806 T18670 T18669 prep with,interfere
R12807 T18671 T18670 pobj sequences,with
R12808 T18672 T18671 punct ",",sequences
R12809 T18673 T18674 nsubj which,seem
R12810 T18674 T18671 relcl seem,sequences
R12811 T18675 T18676 aux to,be
R12812 T18676 T18674 xcomp be,seem
R12813 T18677 T18676 acomp crucial,be
R12814 T18678 T18677 prep for,crucial
R12815 T18679 T18680 det the,binding
R12816 T18680 T18678 pobj binding,for
R12817 T18681 T18680 prep of,binding
R12818 T18682 T18685 nmod NFAT,proteins
R12819 T18683 T18682 cc and,NFAT
R12820 T18684 T18682 conj NFκB,NFAT
R12821 T18685 T18681 pobj proteins,of
R12822 T18686 T18676 punct ",",be
R12823 T18687 T18676 advmod respectively,be
R12824 T18688 T18667 punct .,reported
R12825 T18689 T18695 advmod Afterwards,purified
R12826 T18690 T18695 punct ",",purified
R12827 T18691 T18693 det the,oligos
R12828 T18692 T18693 compound ds,oligos
R12829 T18693 T18695 nsubjpass oligos,purified
R12830 T18694 T18695 auxpass were,purified
R12831 T18695 T18695 ROOT purified,purified
R12832 T18696 T18695 prep via,purified
R12833 T18697 T18698 compound gel,filtration
R12834 T18698 T18696 pobj filtration,via
R12835 T18699 T18695 advcl using,purified
R12836 T18700 T18701 compound Probe,Quant
R12837 T18701 T18704 compound Quant,Columns
R12838 T18702 T18704 compound G-50,Columns
R12839 T18703 T18704 compound Micro,Columns
R12840 T18704 T18699 dobj Columns,using
R12841 T18705 T18704 punct (,Columns
R12842 T18706 T18704 appos Pharmacia,Columns
R12843 T18707 T18704 punct ),Columns
R12844 T18708 T18695 prep according,purified
R12845 T18709 T18708 prep to,according
R12846 T18710 T18711 det the,manufacturer
R12847 T18711 T18713 poss manufacturer,instructions
R12848 T18712 T18711 case 's,manufacturer
R12849 T18713 T18709 pobj instructions,to
R12850 T18714 T18695 punct .,purified

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T18512 707-714 Positive_regulation denotes crucial
T18511 707-714 Positive_regulation denotes crucial
T18510 723-730 Binding denotes binding
T18509 723-730 Binding denotes binding
T18508 570-578 Entity denotes promoter
T18507 743-756 Protein denotes NFκB proteins
T18506 734-738 Protein denotes NFAT
T18505 623-636 Protein denotes TNFα promoter
T18504 595-615 Protein denotes κ consensus sequence
T18503 565-569 Protein denotes IFNγ
T18502 550-557 Protein denotes P2 site
T18501 346-349 Protein denotes PNK
T18500 341-344 Protein denotes Kit
T18499 80-109 Protein denotes IL-8, IFNγ and IL-6 promoters
T18498 74-78 Protein denotes TNFα
R12657 T18502 T18508 partOf P2 site,promoter
R12658 T18503 T18508 partOf IFNγ,promoter
R12659 T18506 T18509 themeOf NFAT,binding
R12660 T18507 T18510 themeOf NFκB proteins,binding
R12661 T18509 T18511 themeOf binding,crucial
R12662 T18510 T18512 themeOf binding,crucial

testone

Id Subject Object Predicate Lexical cue
T18250 723-730 Binding denotes binding
T18249 707-714 Positive_regulation denotes crucial
T18248 533-542 Negative_regulation denotes Mutations
T18247 447-454 Binding denotes binding
T18246 734-738 Protein denotes NFAT
T18245 623-627 Protein denotes TNFα
T18244 565-569 Protein denotes IFNγ
T18243 95-99 Protein denotes IL-6
T18242 86-90 Protein denotes IFNγ
T18241 80-84 Protein denotes IL-8
T18240 74-78 Protein denotes TNFα
R12462 T18246 T18250 themeOf NFAT,binding
R12463 T18250 T18249 themeOf binding,crucial

test3

Id Subject Object Predicate Lexical cue
T18260 86-90 Protein denotes IFNγ
T18259 80-84 Protein denotes IL-8
T18258 74-78 Protein denotes TNFα
T18257 734-738 Protein denotes NFAT
T18256 623-627 Protein denotes TNFα
T18255 565-569 Protein denotes IFNγ
T18254 95-99 Protein denotes IL-6
T18253 86-90 Protein denotes IFNγ
T18252 80-84 Protein denotes IL-8
T18251 74-78 Protein denotes TNFα
T18266 734-738 Protein denotes NFAT
T18265 723-730 Binding denotes binding
T18264 707-714 Positive_regulation denotes crucial
T18263 623-627 Protein denotes TNFα
T18262 565-569 Protein denotes IFNγ
T18261 95-99 Protein denotes IL-6
R12464 T18265 T18264 themeOf binding,crucial
R12465 T18266 T18265 themeOf NFAT,binding